Correlation Between Pfizer and ECOPET
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and ECOPET 5875 02 NOV 51, you can compare the effects of market volatilities on Pfizer and ECOPET and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ECOPET. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ECOPET.
Diversification Opportunities for Pfizer and ECOPET
Poor diversification
The 3 months correlation between Pfizer and ECOPET is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ECOPET 5875 02 NOV 51 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ECOPET 5875 02 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ECOPET. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ECOPET 5875 02 has no effect on the direction of Pfizer i.e., Pfizer and ECOPET go up and down completely randomly.
Pair Corralation between Pfizer and ECOPET
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the ECOPET. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.18 times less risky than ECOPET. The stock trades about -0.26 of its potential returns per unit of risk. The ECOPET 5875 02 NOV 51 is currently generating about -0.21 of returns per unit of risk over similar time horizon. If you would invest 6,956 in ECOPET 5875 02 NOV 51 on August 29, 2024 and sell it today you would lose (568.00) from holding ECOPET 5875 02 NOV 51 or give up 8.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 91.3% |
| Values | Daily Returns |
Pfizer Inc vs. ECOPET 5875 02 NOV 51
Performance |
| Timeline |
| Pfizer Inc |
| ECOPET 5875 02 |
Pfizer and ECOPET Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and ECOPET
The main advantage of trading using opposite Pfizer and ECOPET positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ECOPET can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ECOPET will offset losses from the drop in ECOPET's long position.| Pfizer vs. Pharvaris BV | Pfizer vs. Brinker International | Pfizer vs. Alcoa Corp | Pfizer vs. Direxion Daily FTSE |
| ECOPET vs. Acco Brands | ECOPET vs. Weyco Group | ECOPET vs. NL Industries | ECOPET vs. Franklin Wireless Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |